Detalhe da pesquisa
1.
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease.
Blood
; 141(11): 1277-1292, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044666
2.
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.
Blood
; 142(18): 1570-1575, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595284
3.
Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.
Blood
; 136(19): 2188-2199, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750121
4.
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Blood Adv
; 7(4): 664-679, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083130
5.
Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis.
Front Immunol
; 10: 3045, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31998317